Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovaza for Breast Cancer Risk Biomarkers
NCT01252290Phase 2Completed
- Start
- Nov 2010
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eicosapentaenoic acid + docosahexaenoic acid in breast cancer. Started Nov 2010; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01252290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01252290.